Dasatinib Receives FDA Approval for Pediatric Ph+ Acute Lymphoblastic Leukemia

Press/Media

Period	2 Jan 2019

Media coverage

Title	Dasatinib Receives FDA Approval for Pediatric Ph+ Acute Lymphoblastic Leukemia
Media name/outlet	Specialty Pharmacy Times
Country/Territory	United States
Date	2/01/19
URL	https://www.specialtypharmacytimes.com/news/dasatinib-receives-fda-approval-for-pediatric-ph-acute-lymphoblastic-leukemia
Persons	Stephen Hunger